...
首页> 外文期刊>Biotechnology Progress >Semi‐continuous scale‐down models for clone and operating parameter screening in perfusion bioreactors
【24h】

Semi‐continuous scale‐down models for clone and operating parameter screening in perfusion bioreactors

机译:灌注生物反应器中克隆和操作参数筛选的半连续缩小模型

获取原文
获取原文并翻译 | 示例
           

摘要

> Perfusion cell culture, confined traditionally to the production of fragile molecules, is currently gaining broader attention in the biomanufacturing of therapeutic proteins. The development of these processes is made difficult by the limited availability of appropriate scale‐down models. This is due to the continuous operation that requires complex control and cell retention capacity. For example, the determination of an optimal perfusion and bleed rate for continuous cell culture is often performed in scale‐down bioreactors and requires a substantial amount of time and effort. To increase the experimental throughput and decrease the required workload, a semi‐continuous procedure, referred to as the VCD max (viable cell density) approach, has been developed on the basis of shake tubes (ST) and deepwell plates (96‐DWP). Its effectiveness has been demonstrated for 12 different CHO‐K1‐SV cell lines expressing an IgG1. Further, its reliability has been investigated through proper comparisons with perfusion runs in lab‐scale bioreactors. It was found that the volumetric productivity and the CSPR min (cell specific perfusion rate) determined using the ST and 96‐DWP models were successfully (mostly within the experimental error) confirmed in lab‐scale bioreactors, which then covered a significant scale‐up from the half milliliter to the liter scale. These scale‐down models are very useful to design and scale‐up optimal bioreactor operating conditions as well as screening for different media and cell lines.
机译: > 灌注细胞培养传统上限于脆性分子的生产,目前在治疗蛋白的生物制造中正在更广泛地关注。通过适当的缩放模型的有限可用性,这些过程的开发是困难的。这是由于需要复杂控制和细胞保留容量的连续操作。例如,测定用于连续细胞培养的最佳灌注和渗出速率通常在鳞片下的生物反应器中进行,并且需要大量的时间和努力。为了提高实验吞吐量并减少所需的工作量,半连续程序,称为VCD max (可行的细胞密度)方法是基于摇管(ST)和Depell Plates(96-DWP)开发的方法。已经证明了12种不同的CHO-K1-SV细胞系表达IgG1的有效性。此外,通过对Lab-Scale生物反应器中的灌注运行进行了适当的比较来研究其可靠性。发现体积生产力和CSPR min (使用ST和96DWP模型测定的细胞特异性灌注速率)成功(主要在实验误差内)确认在实验室级生物反应器中,然后从半毫升到升量表中覆盖显着扩大。这些缩小的模型对于设计和扩大最佳的生物反应器操作条件以及对不同介质和细胞系的筛选非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号